HPR125 Novel Drug Approvals By the U.S. Food and Drug Administration in Rare Diseases: Findings from 2020–2023

Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.2356
https://www.valueinhealthjournal.com/article/S1098-3015(24)02570-1/fulltext
Section Title :
Section Order : 10602
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)02570-1&doi=10.1016/j.jval.2024.03.2356
HEOR Topics :
Tags :
Regions :